Islet cell carcinoma of the pancreas. A study of 98 patients
- 15 January 1990
- Vol. 65 (2) , 354-357
- https://doi.org/10.1002/1097-0142(19900115)65:2<354::aid-cncr2820650229>3.0.co;2-n
Abstract
In 98 patients with histologically proved pancreatic islet cell carcinoma who were studied between 1950 and 1987, 55 had functioning tumors and 43 had nonfunctioning tumors. Both patient groups were compared in regard to age at presentation, metastases, and survival. Mean age at diagnosis was 51.1 years for the 55 men and 47 years for the 43 women. At diagnosis, 51 of the patients had regional disease and 47 had distant metastases. When matched for age, sex, and extent of disease, survival did not differ significantly in cases of functioning and nonfunctioning tumors. The patients' ages and the extent of disease at presentation were the most significant factors in prognosis and survival.This publication has 5 references indexed in Scilit:
- Management of Nonfunctioning Islet Cell Tumors of the PancreasSurgical Clinics of North America, 1985
- Tumors of the Endocrine PancreasNew England Journal of Medicine, 1982
- Pancreatic Islet Cell CarcinomaAnnals of Internal Medicine, 1973
- Epidemiology of Pancreatic Cancer in ConnecticutGastroenterology, 1968